KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹42 Cr | ₹43 Cr | ₹34 Cr | ₹-33 Cr | ₹60 Cr |
What is the latest Cash Flow from Operating Activities ratio of KOPRAN ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹42 Cr |
| Mar2024 | ₹43 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹-33 Cr |
| Mar2021 | ₹60 Cr |
How is Cash Flow from Operating Activities of KOPRAN Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹42 Cr | -3.04 | |
| Mar2024 | ₹43 Cr | 27.14 | |
| Mar2023 | ₹34 Cr | Positive | |
| Mar2022 | ₹-33 Cr | Negative | |
| Mar2021 | ₹60 Cr | - | |
Compare Cash Flow from Operating Activities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹770.9 Cr | 1.6% | 36.9% | -11.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 1.6% |
36.9% |
-11.7% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses